Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma

被引：15

作者：

Thompson, P. A. ^{[1
]}

Prince, H. M. ^{[1
,2
]}

Seymour, J. F. ^{[1
,2
]}

Ritchie, D. ^{[1
,2
]}

Stokes, K. ^{[1
]}

Burbury, K. ^{[1
]}

Wolf, M. ^{[1
]}

Peinert, S. ^{[1
]}

Joyce, T. ^{[1
]}

Harrison, S. J. ^{[1
,2
]}

机构：

[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[2] Univ Melbourne, Fac Med, Parkville, Vic 3052, Australia

来源：

BONE MARROW TRANSPLANTATION | 2011年 / 46卷 / 05期

关键词：

STEM-CELL TRANSPLANTATION; PROTEASOME; PHASE-2;

D O I：

10.1038/bmt.2010.180

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：764 / 765

页数：2

共 9 条

[1] The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study [J].

Bird, Jennifer M. ;

Fuge, Rhian ;

Sirohi, Bhawna ;

Apperley, Jane F. ;

Hunter, Ann ;

Snowden, John ;

Mahendra, Premini ;

Milligan, Donald ;

Byrne, Jenny ;

Littlewood, Timothy ;

Fegan, Christopher ;

McQuaker, Grant ;

Pagliuca, Antonio ;

Johnson, Peter ;

Rahemtulla, Amin ;

Morris, Curly ;

Marks, David I. .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (04) :385-390

[2] International uniform response criteria for multiple myeloma [J].

Durie, B. G. M. ;

Harousseau, J-L ;

Miguel, J. S. ;

Blade, J. ;

Barlogie, B. ;

Anderson, K. ;

Gertz, M. ;

Dimopoulos, M. ;

Westin, J. ;

Sonneveld, P. ;

Ludwig, H. ;

Gahrton, G. ;

Beksac, M. ;

Crowley, J. ;

Belch, A. ;

Boccadaro, M. ;

Turesson, I. ;

Joshua, D. ;

Vesole, D. ;

Kyle, R. ;

Alexanian, R. ;

Tricot, G. ;

Attal, M. ;

Merlini, G. ;

Powles, R. ;

Richardson, P. ;

Shimizu, K. ;

Tosi, P. ;

Morgan, G. ;

Rajkumar, S. V. .

LEUKEMIA, 2006, 20 (09) :1467-1473

[3]

GIRALT S, 2007, HAEMATOLOGICA, V92, P2

[4] The role of complete response in multiple myeloma [J].

Harousseau, Jean-Luc ;

Attal, Michel ;

Avet-Loiseau, Herve .

BLOOD, 2009, 114 (15) :3139-3146

[5] A Randomized Phase I Study of Melphalan and Bortezomib for Autologous Transplant in Myeloma [J].

Kaufman, J. L. ;

Lonial, S. ;

Sinha, R. ;

Torre, C. ;

Langston, A. A. ;

Lechowicz, M. J. ;

Flowers, C. ;

McMillan, S. ;

Renfroe, H. ;

Heffner, L. T. ;

Waller, E. K. .

CLINICAL LYMPHOMA & MYELOMA, 2009, 9 :S60-S60

[6] The proteasome - An emerging therapeutic target in cancer [J].

Mitchell, BS .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2597-2598

[7] The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications [J].

Mitsiades, N ;

Mitsiades, CS ;

Richardson, PG ;

Poulaki, V ;

Tai, YT ;

Chauhan, D ;

Fanourakis, G ;

Gu, XS ;

Bailey, C ;

Joseph, M ;

Libermann, TA ;

Schlossman, R ;

Munshi, NC ;

Hideshima, T ;

Anderson, KC .

BLOOD, 2003, 101 (06) :2377-2380

[8] A phase 2 study of bortezomib in relapsed, refractory myeloma [J].

Richardson, PG ;

Barlogie, B ;

Berenson, J ;

Singhal, S ;

Jagannath, S ;

Irwin, D ;

Rajkumar, SV ;

Srkalovic, G ;

Alsina, M ;

Alexanian, R ;

Siegel, D ;

Orlowski, RZ ;

Kuter, D ;

Limentani, SA ;

Lee, S ;

Hideshima, T ;

Esseltine, DL ;

Kauffman, M ;

Adams, J ;

Schenkein, DP ;

Anderson, KC .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2609-2617

[9] Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM) [J].

Roussel, Murielle ;

Moreau, Philippe ;

Huynh, Anne ;

Mary, Jean-Yves ;

Danho, Clotaire ;

Caillot, Denis ;

Hulin, Cyrille ;

Fruchart, Christophe ;

Marit, Gerald ;

Pegourie, Brigitte ;

Lenain, Pascal ;

Araujo, Carla ;

Kolb, Brigitte ;

Randriamalala, Edouard ;

Royer, Bruno ;

Stoppa, Anne-Marie ;

Dib, Mammoun ;

Dorvaux, Veronique ;

Garderet, Laurent ;

Mathiot, Claire ;

Avet-Loiseau, Herve ;

Harousseau, Jean-Luc ;

Attal, Michel .

BLOOD, 2010, 115 (01) :32-37

← 1 →